News Conference News The Structural Heart Disease Summit 2018 PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial Shelley Wood June 23, 2018
News Conference News The Structural Heart Disease Summit 2018 High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense? Michael O'Riordan June 22, 2018
News Conference News The Structural Heart Disease Summit 2018 Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions Shelley Wood June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Updated Amulet Outcomes and Ongoing Studies in Anticoagulant Indicated and Contraindicated Patients Presenter: William A. Gray, Gregg W. Stone, DJ Lakkireddy June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Updated Watchman Results in Anticoagulant Indicated and Contraindicated Patients: Randomized Trials and Registries Presenter: William A. Gray, Gregg W. Stone, Matthew J. Price June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Indications and Uncertainties for Atrial Fibrillation Treatment: Risk Scores, Single AF Episode, Post-CABG AF, Valvular vs. Nonvalvular, and More Presenter: William A. Gray, Gregg W. Stone, Vivek Y. Reddy June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Electrical Approaches to NVAF in 2018 (Standalone or in Combination With LAA Occlusion): Evidence and Practical Recommendations Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Shephal Doshi June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Gregg W. Stone June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Diagnostic Evaluation: Historical Requirements and Emerging Evidence (LHC, TTE, TEE, CTA, Carotid US, PFTs) Presenter: Kim Guibone June 21, 2018